See analyst estimates and all valuation multiples for Health & Beauty
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $402B | 4.8x | 17.3x | |
| $396B | 6.8x | 15.0x | |
| $239B | 4.6x | 19.4x | |
| $178B | 2.5x | 12.1x | |
| $82.8B | 4.1x | 16.7x | |
| $68.7B | 1.3x | 6.0x | |
| $65.0B | 8.7x | 38.0x | |
| $57.4B | 3.0x | 10.6x | |
| $56.3B | 3.7x | 14.7x | |
| $49.8B | 5.2x | 21.7x | |
| $47.9B | 3.1x | 13.1x | |
| $38.5B | 7.8x | 34.0x | |
| $37.6B | 2.6x | 19.5x | |
| $33.0B | 1.3x | 7.3x | |
| $25.6B | 2.2x | 12.4x | |
| $25.4B | 4.2x | 18.1x | |
| $22.9B | 2.3x | 6.5x | |
| $22.9B | 2.0x | 13.0x | |
| $22.0B | 1.5x | 8.0x | |
| $20.1B | 1.7x | 11.8x | |
| $15.2B | 8.8x | 41.7x | |
| $12.3B | 8.2x | 32.3x | |
| $12.1B | 2.1x | 10.4x | |
| $12.0B | 2.1x | 15.0x | |
| $10.9B | 8.3x | 41.9x | |
| $10.5B | 1.5x | 8.1x | |
| $10.4B | 7.0x | 37.4x | |
| $8.9B | 1.3x | 12.6x | |
| $8.3B | 1.4x | 7.7x | |
| $7.8B | 10.8x | 33.3x | |
| $7.1B | 5.0x | 23.3x | |
| $6.9B | 1.6x | 9.1x | |
| $6.8B | 7.8x | 18.6x | |
| $6.6B | 2.3x | 10.6x | |
| $6.2B | 13.8x | 43.7x | |
| $5.7B | 1.9x | 13.6x | |
| $5.0B | n/a | n/a | |
| $5.0B | 9.8x | 41.0x | |
| $4.8B | 4.2x | 12.8x | |
| $4.4B | 3.0x | 14.7x | |
| $4.3B | 1.2x | 7.3x | |
| $4.1B | 5.9x | 27.6x | |
| $4.1B | 5.6x | 26.4x | |
| $4.1B | 12.4x | 50.1x | |
| $4.0B | 3.8x | 25.9x | |
| $4.0B | 2.4x | 13.0x | |
| $3.8B | 1.7x | 11.5x | |
| $3.3B | 3.1x | 14.0x | |
| $3.2B | 1.0x | 6.2x | |
| $3.0B | 1.4x | 8.1x | |
| $3.0B | 0.6x | 5.7x | |
| $2.9B | 6.3x | 23.2x | |
| $2.6B | 0.8x | 5.2x | |
| $2.5B | 1.4x | 12.1x | |
| $2.5B | 1.1x | 7.2x | |
| $2.4B | 1.3x | 10.0x | |
| $2.4B | 2.1x | -103.5x | |
| $2.4B | 1.2x | 9.2x | |
| $2.3B | 0.9x | 4.6x | |
| $2.3B | 0.8x | 6.7x | |
| $2.3B | 3.5x | 16.9x | |
| $2.2B | 2.6x | 17.1x | |
| $2.0B | 3.3x | 19.1x | |
| $1.9B | 4.7x | 13.3x | |
| $1.7B | 0.8x | 8.3x | |
| $1.6B | 0.9x | 6.0x | |
| $1.6B | 1.3x | 10.6x | |
| $1.6B | 1.2x | 9.1x | |
| $1.6B | 2.6x | 10.7x | |
| $1.4B | 0.7x | 5.6x | |
| $1.4B | 4.7x | 10.6x | |
| $1.1B | 1.6x | 6.6x | |
| $1.1B | 7.8x | 27.6x | |
| $1.1B | 2.6x | 10.0x | |
| $1.1B | n/a | n/a | |
| $1.1B | 4.2x | 97.1x | |
| $1.0B | 1.4x | 10.2x | |
| $993M | 0.3x | 2.3x | |
| $775M | n/a | n/a | |
| $706M | n/a | n/a | |
| $652M | 2.1x | -132.8x | |
| $627M | 1.4x | 6.6x | |
| $581M | 0.8x | 4.2x | |
| $579M | 0.8x | 6.0x | |
| $545M | 2.2x | 22.9x | |
| $532M | 0.4x | 4.9x | |
| $528M | 0.3x | n/a | |
| $503M | 1.3x | 8.4x | |
| $497M | 1.3x | 18.1x | |
| $494M | 1.7x | 11.3x | |
| $472M | 1.5x | 28.8x | |
| $464M | 3.0x | 11.8x | |
| $415M | n/a | n/a | |
| $387M | 1.9x | -26.4x | |
| $358M | 1.4x | n/a | |
| $352M | n/a | n/a | |
| $335M | n/a | n/a | |
| $321M | 0.8x | 9.5x | |
| $280M | n/a | n/a | |
| $263M | 5.4x | 20.0x | |
| $259M | 1.3x | 7.9x | |
| $208M | 0.4x | 9.2x | |
| $193M | 1.0x | 10.5x | |
| $192M | n/a | n/a | |
| $159M | n/a | n/a | |
| $144M | 0.5x | 6.0x | |
| $137M | 2.3x | 7.5x | |
| $136M | 2.1x | 9.4x | |
| $105M | n/a | n/a | |
| $93.1M | 0.4x | 4.9x | |
| $61.5M | 1.2x | 9.3x | |
| $55.9M | 2.1x | 8.7x | |
| $48.0M | n/a | n/a | |
| $43.0M | n/a | n/a | |
| $32.5M | n/a | n/a | |
| $20.7M | 0.8x | -28.2x | |
| $19.8M | 1.5x | n/a | |
| $19.5M | n/a | n/a | |
| $14.7M | n/a | n/a | |
| $13.0M | n/a | n/a | |
| $12.3M | n/a | n/a | |
| $10.9M | 0.0x | 0.5x | |
| $7.3M | n/a | n/a | |
| $1.0M | n/a | n/a | |
| $0.6M | n/a | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Health & Beauty